Purchase Order HHSN268201700051A

<p>The National Heart Lung and Blood Institute awarded a purchase order to Illumina, Inc. for an MiSeq 2 sequencer assembly (catalog 15033616) valued at $95,931.00 on September 26, 2017, with completion by October 26, 2017. Performance occurs at Bethesda, Maryland 20892. The order is a firm fixed-price acquisition of this proprietary genomic sequencing instrument, no set-aside designation applied.</p>

<p>The National Heart Lung and Blood Institute issued a delivery order to Illumina, Inc. on December 7, 2017, with a ceiling value of $44,198.64 for a HISEQ 3000 SR Cluster Kit.</p> <p>Place of performance is San Diego, CA 92122. The order is firm fixed price with no set-aside designation and an ultimate completion date of September 2, 2020.</p>

<p>The National Institute of Child Health and Human Development awarded a purchase order to Illumina, Inc. for $102,585.72 on December 15, 2016, with a completion date of December 15, 2017. The order covers a comprehensive maintenance plan for HiSeq and MiSeq sequencers. Place of performance is Bethesda, Maryland. Pricing is firm fixed price.</p>

The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $130,000 purchase order to Illumina, Inc. for maintenance on the NovaSeq and MiSeq equipment used for sequencing services. The contract has a one-year period of performance from September 2021 through September 2022 and utilizes a firm fixed price contract type. Illumina will provide maintenance and support services on sequencing equipment located in San Diego, California...

This firm fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $184,285.77 contract is for maintenance services on the government-owned Illumina NovaSeq 6000 genetic sequencing equipment, to ensure it operates safely and with minimal downtime. The original solicitation called for the contractor...

This is a firm fixed price federal contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. to provide the HiSeq 2500 sequencing system to the NHLBI Division of Intramural Research (DIR). The contract has a ceiling value of $647,403.80 and a period of performance ending on March 24, 2015. There is no set-aside designation associated with this award. Illumina, Inc. is a manufacturer and provider of...

<p>The National Heart Lung and Blood Institute awarded a purchase order to Illumina, Inc. for a NovaSeq 6000 Sequencing System valued at $902,700 on August 27, 2019. Work is performed in San Diego, California. The order is firm fixed price with no set-aside designation. Ultimate completion is scheduled for April 10, 2020. The solicitation was posted August 7, 2019, with a due date of August 14, 2019.</p>

The National Heart Lung and Blood Institute awarded a purchase order to Illumina, Inc. valued at $190,561.89 on June 5, 2018, with final completion on June 4, 2019. The order is firm fixed-price with no set-aside designation. Place of performance is Bethesda, Maryland. The purchase order covers Illumina service contract requirements, typical of the vendor's federal work providing genetic sequencing systems, reagents, and bioinformatics support to research institutions across civilian agencies.

<p>The National Heart Lung and Blood Institute issued a $23,099 delivery order to Illumina, Inc. on November 18, 2014, for genetic sequencing equipment and related supplies, with performance at Bethesda, MD and completion by August 31, 2015.</p> <p>The order is firm fixed price with no set-aside designation.</p>

This is a $15,849.80 firm fixed price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the maintenance of a MiSeq M06580 DNA sequencing instrument and associated services. The contract has a period of performance through September 11, 2026. Illumina, a manufacturer of genomic sequencing technologies, has been awarded multiple federal contracts and grants by the NIH, Centers...